Suchergebnisse - "Lindegaard, Hanne"

PubPharm (17)

1

Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission : 5-year follow-up of the IMAGINE-RA randomised trial

enthalten in: RMD open | 2024

von Møller-Bisgaard, S. | Hørslev-Petersen, K. | Ørnbjerg, L. | +18

2

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis : 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

enthalten in: Annals of the rheumatic diseases | 2023

von Østergaard, M. | van Vollenhoven, R. | Rudin, A. | +96

3

Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission

enthalten in: Rheumatology (Oxford, England) | 2021

von Møller-Bisgaard, S. | Georgiadis, S. | Hørslev-Petersen, K. | +24

CommentIn: Rheumatology (Oxford). 2021 Jan 5;60(1):3-4. - PMID 33175981

4

Active conventional treatment and three different biological treatments in early rheumatoid arthritis : phase IV investigator initiated, randomised, observer blinded clinical trial

enthalten in: BMJ (Clinical research ed.) | 2020

von Hetland, M. | Haavardsholm, E. | Rudin, A. | +96

5

Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis : The IMAGINE-RA Randomized Clinical Trial

enthalten in: JAMA | 2019

von Møller-Bisgaard, S. | Hørslev-Petersen, K. | Ejbjerg, B. | +25

CommentIn: JAMA. 2019 Feb 5;321(5):457-458. - PMID 30721278

6

Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients : Results of a Randomized Controlled Trial

enthalten in: The Journal of rheumatology | 2017

von Nguyen, M. | Lindegaard, H. | Hendricks, O. | +3

7

Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis : longitudinal results from two randomised controlled trials

enthalten in: Annals of the rheumatic diseases | 2017

von Glinatsi, D. | Baker, J. | Hetland, M. | +17

8

A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : results from the OPERA randomised controlled trial

enthalten in: Annals of the rheumatic diseases | 2015

von Axelsen, M. | Eshed, I. | Hørslev-Petersen, K. | +21

9

Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis : results from the nationwide registries DANBIO and ICEBIO

enthalten in: Rheumatology (Oxford, England) | 2014

von Glintborg, B. | Gudbjornsson, B. | Krogh, N. | +13

10

Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial

enthalten in: Annals of the rheumatic diseases | 2014

von Hørslev-Petersen, K. | Hetland, M. | Junker, P. | +27